AltheaDX Nixes IPO As 3 Other Diagnostic Cos. Eye Debuts
Molecular diagnostic company AltheaDX Inc. withdrew plans to raise up to $65 million in an initial public offering Monday after postponing pricing last month, as another diagnostic company lies in wait...To view the full article, register now.
Already a subscriber? Click here to view full article